BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 7451649)

  • 1. Influence of prostaglandin synthesis inhibitors on pulmonary vasodilatory effects of hydralazine in dogs with hypoxic pulmonary vasoconstriction.
    Rubin LJ; Lazar JD
    J Clin Invest; 1981 Jan; 67(1):193-200. PubMed ID: 7451649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of eicosanoid synthesis inhibitors on normoxic and hypoxic pulmonary vascular tone in dogs.
    Rubin LJ; Hughes JD; Lazar JD
    Am Rev Respir Dis; 1985 Jul; 132(1):93-8. PubMed ID: 3925829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandins participate in the renal vasodilation due to hydralazine in dogs.
    Panzenbeck M; Baez A; Kaley G
    J Pharmacol Exp Ther; 1986 May; 237(2):525-8. PubMed ID: 3084759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effect of hydralazine administration on pulmonary artery hemodynamics in dogs with chronic heartworm disease.
    Atkins CE; Keene BW; McGuirk SM; Sato T
    Am J Vet Res; 1994 Feb; 55(2):262-9. PubMed ID: 8172418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostacyclin (PGI2) induces coronary vasodilatation in anaesthetised dogs.
    Dusting GJ; Chapple DJ; Hughes R; Moncada S; Vane JR
    Cardiovasc Res; 1978 Dec; 12(12):720-30. PubMed ID: 376143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasodilative effect of hydralazine in awake dogs: the roles of prostaglandins and the sympathetic nervous system.
    Maekawa K; Liang CS; Tsui A; Chen BT; Kawashima S
    Circulation; 1984 Nov; 70(5):908-16. PubMed ID: 6488504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute hemodynamic effects of hydralazine in dogs with chronic mitral regurgitation.
    Kittleson MD; Johnson LE; Oliver NB
    J Am Vet Med Assoc; 1985 Aug; 187(3):258-61. PubMed ID: 4030462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic and coronary hemodynamic effects of pinacidil, a new antihypertensive agent, in awake dogs: comparison with hydralazine.
    Kawashima S; Liang CS
    J Pharmacol Exp Ther; 1985 Feb; 232(2):369-75. PubMed ID: 3968638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiopulmonary effects of intravenous prostaglandin E1 during experimental one-lung ventilation.
    Bund M; Henzler D; Walz R; Rossaint R; Piepenbrock S
    Thorac Cardiovasc Surg; 2006 Aug; 54(5):341-7. PubMed ID: 16902884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonadrenergic effects of isoproterenol in dogs with hypoxic pulmonary vasoconstriction. Possible role of prostaglandins.
    Rubin LJ; Lazar JD
    J Clin Invest; 1983 May; 71(5):1366-74. PubMed ID: 6406548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of cyclo-oxygenase inhibitors on the cardiovascular effects of hydralazine in rats.
    Vidrio H; Garcia-Marquez F
    Arch Int Pharmacodyn Ther; 1985 Jan; 273(1):131-41. PubMed ID: 3923959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of hydralazine on regional blood flow in conscious dogs.
    Chelly JE; Doursout MF; Begaud B; Tsao CC; Hartley CJ
    J Pharmacol Exp Ther; 1986 Aug; 238(2):665-9. PubMed ID: 3735136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydralazine does not inhibit canine hypoxic pulmonary vasoconstriction.
    Bishop MJ; Kennard S; Artman LD; Cheney FW
    Am Rev Respir Dis; 1983 Dec; 128(6):998-1001. PubMed ID: 6650991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pulmonary vasoconstrictor response to hypoxia: effects of inhibitors of prostaglandin biosynthesis.
    Vaage J; Bjertnaes L; Hauge A
    Acta Physiol Scand; 1975 Sep; 95(1):95-101. PubMed ID: 1180109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endotoxin and prevention of hypoxic pulmonary vasoconstriction.
    Weir EK; Mlczoch J; Reeves JT; Grover RF
    J Lab Clin Med; 1976 Dec; 88(6):975-83. PubMed ID: 1033260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of indomethacin and meclofenamate on canine mesenteric and celiac blood flow.
    Gaffney GR; Williamson HE
    Res Commun Chem Pathol Pharmacol; 1979 Jul; 25(1):165-8. PubMed ID: 451350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cyclooxygenase inhibition on the pulmonary vasodilator response to furosemide.
    Lundergan CF; Fitzpatrick TM; Rose JC; Ramwell PW; Kot PA
    J Pharmacol Exp Ther; 1988 Jul; 246(1):102-6. PubMed ID: 3134540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of indomethacin on cardiovascular hemodynamics of goats in hemorrhagic shock.
    Leffler CW; Tyler TL; Cassin S
    Circ Shock; 1978; 5(3):299-310. PubMed ID: 709735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
    Jackson EK; Dubinion JH; Mi Z
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moderation of hypoxic vasoconstriction by infused arachidonic acid: role of PGI2.
    Gerber JG; Voelkel N; Nies AS; McMurtry IF; Reeves JT
    J Appl Physiol Respir Environ Exerc Physiol; 1980 Jul; 49(1):107-12. PubMed ID: 6995413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.